fig5
Figure 5. Effect of Muno-IgY® on the Beta-diversity of the treatment groups. Principal coordinates analysis (PCoA) was performed on Bray-Curtis dissimilarity matrices to evaluate the effect of Muno-IgY® on the β-diversity. Statistical differences in overall community composition were tested using PERMANOVA. No significant separation was observed between Control and Muno-IgY® groups in either the (A) lumen (P = 0.1) or (B) mucus (P = 0.1) compartments. IgY: Immunoglobulin Y. PERMANOVA: Permutational multivariate analysis of variance.







